Loading
No insider purchase over the last 90 days. The latest, by 姜烨, was filed 21 Aug 2025.
Beihai Gofar Chuanshan Biological Co., Ltd.: what insiders have been doing
Beihai Gofar Chuanshan Biological Co., Ltd. belongs to the Chemicals sector. Filings by its managers are published through SSE / SZSE (CSRC). From 26 October 2025 to 26 October 2026, the disclosure feed for Beihai Gofar Chuanshan Biological Co., Ltd. logged 3 filings by 1 insider.
Only sales appear on the open market, 3 sales in all totalling €631k, filed by 1 insider. At €349k, the sale published on 16 June 2026 by 姜烨 is the largest of the period.
Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 515 companies) published 2 filings over the same period, against 3 filings here. Our records for Beihai Gofar Chuanshan Biological Co., Ltd. go back to 2023, with 4 purchases and 6 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€3M
4 ops. · all time
Sell Volume
€2M
6 ops. · all time
Who traded when
BuySale姜烨4 buys3 sales
Since the insiders bought
- -11.6%Entry CN¥6.55 · Close at T+90 CN¥5.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,179 of 26,320 companies
23.7
score / 100
Value29
Quality19
FCF yld-0.8%
Earn yld-3.5%
EV/EBITDA·
ROE-12%
Gross mgn22%
Net mgn-27%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥4.78
Analyst consensus
Income statement
RevenueCN¥328.2M
Gross profitCN¥73.7M22% margin
EBITDA-CN¥64.4M-20% margin
Net income-CN¥87.6M-27.9% margin
Valuation
P/Book3.7x
Beta0.24
Balance sheet & cash
Market capCN¥2.5B
Total debtCN¥55.9M
Free Cash Flow-CN¥19.9M
Debt / Equity10%
Profitability & ownership
ROE-12.5%
ROA-1.5%
% insiders19.1%
% institutions1.2%
Last declaration on 17 June 2026
Declarations10 total
373,100 shares@ CN¥45.10767.0% of flowA股XSHGSSE:273000000742722140
460,900 shares@ CN¥46.65418.8% of flowA股XSHGSSE:273000000738828900
4,900 shares@ CN¥45.64520.1% of flowA股XSHGSSE:273000000731437800
1,868,600 shares36.1% of flowA股XSHGSSE:173000009384363900
Canonical exit: 19 Nov 2025 (T+90)
657,400 shares12.3% of flowA股XSHGSSE:173000009378626000
Canonical exit: 18 Nov 2025 (T+90)
1,600,000 shares29.7% of flowA股XSHGSSE:173000009373390750
Canonical exit: 17 Nov 2025 (T+90)
363,300 shares6.0% of flowA股XSHGSSE:173000009135210720
Canonical exit: 22 Sept 2025 (T+90)
701,300 shares100.0% of flowA股XSHGSSE:173000007200641280
1,704,500 shares98.5% of flowA股XSHGSSE:173000006636279360
25,000 shares1.5% of flowA股XSHGSSE:173000006340034020
10 of 10 declarations
About Beihai Gofar Chuanshan Biological Co., Ltd.
国发股份 is a company specializing in the chemical and materials sector. It is listed on the Shanghai Stock Exchange (XSHG).
